Ursodeoxycholic acid: high-dose, monotherapy or combination therapy?

Research output: Chapter/Conference proceedingChapterAcademic

Original languageUndefined/Unknown
Title of host publicationCholestatic liver diseases therapeutic options and perspectives
Editors- -
Pages301-308
Number of pages8
Publication statusPublished - 2004

Cite this